Blockchain Transaction Record
Leonhardt Ventures Announces Filing of Pioneering Patent Application for Bioelectric Protein Expression of SIRT
SIRT signaling proteins (1-7) are involved in metabolic regulation, inflammation, neurodegeneration, cell cycle/tumorigenesis, Insulin secretion, DNA repair, and rDNA transcription and play a key role during cell response to a variety of stresses, such as oxidative or genotoxic stress.
Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.
Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.
Key Takeaways (TLDR)
- Leonhardt Ventures files pioneering patent covering bioelectric stimulation-controlled expression of SIRT proteins.
- Patent application has over 50 platform-based claims for treating aging-related diseases and conditions.
- Low SIRT levels linked to several diseases, including COVID-19 symptoms, and Leonhardt Ventures aims to upregulate SIRT expression for potential treatment.
| Blockchain | Details |
|---|---|
| Chain | polygon-main |
| Transaction ID | 0x0a3db6083dde87ab195e52c88b946903c6aac4e6e5f820943cfb59f57b743bfe |
| Contract Address | 0x7C0F04d0e072d3Bd3e6ceD44E7EB0352785db218 |
| NWAI Digital Fingerprint | 299-eb7495b04fe016e48711693df137f68f |
| Registration Timestamp | 2022-08-18T19:29:19+00:00 |
Leonhardt Ventures LLC does not have any other recent news to report at this time.